Different effects of acute and chronic low oxygen on anti-viral capacity in pulmonary and endocrine

An international medical study has brought new findings and related findings are of important reference value for disease prevention. Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory disease closely related to inflammation and changes in the airway structure. Low oxygen is a key element of the pulmonary environment, especially in obstructive diseases.

It can be short-term (such as in acute episodes of asthma) or long-term (such as COPD). ECs are an important part of the immune response and are also exposed to low-oxygen and viral infections. Although it has been shown that ECs can be infected by respiratory viruses (RSV) and low-oxygen environments (O2) and low-oxygen environments (O2)) can affect their function, the effects of low-oxygen environments (O2) on the preventive antiviral ability of ECs remain unclear.

This study explores the effects of acute and chronic deoxygen on the antiviral effects of human pulmonary and microbial ECs. Acute and chronic deoxygenation, respectively, modulate the expression of the intramolecular RNA receptor TLR3 and TLR7 and decrease the expression of the RNA receptor RIG-I and MDA5. Acute deoxygenation suppresses the expression of IRF3 and IRF7 proteins and detects the expression of Mx1 (myoprotein receptor) at the mRNA and protein levels by flow cytometry.

In addition, both cause an increase in the secretion of lymphocytes that activate CDKs, while inhibiting the mechanisms of cellular/cellular-associated viral activity. Acute low-oxygen stress suppresses the regulation and effectiveness of antiviral pathways, while chronic low-oxygen stress enhances viral RNA detection and intracellular antiviral mechanisms. These findings highlight the hypothesis that low-oxygen shapes the endogenous immune response and the susceptibility to chronic obstructive pulmonary disease (COPD) viral infections.